FDA Inspection
Symbiosis Pharmaceutical Services LimitedSymbiosis Pharmaceutical Services Limited – FDA Inspection, Jun 13, 2023
Record Details
This FDA Inspection record concerns Symbiosis Pharmaceutical Services Limited, with an inspection on June 13, 2023, issued by the Office of Inspections and Investigations.
- Inspection Date
- June 13, 2023
View Company Profile
ID · 407b2323-be30-4b85-8527-ec38a38b4bb4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1208076
- FDA center
- Human Drugs
FDA Citations
7- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.166(a)(4)Testing in same container - closure system
- 21 CFR 211.170(b)(1)Reserve sample retention time
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Symbiosis Pharmaceutical Services Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | Not classified | Office of Inspections and Investigations | |
| February 23, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Symbiosis Pharmaceutical Services Limited
- FDA Inspection 1266061 - 2025-01-31
- FDA Inspection 1045937 - 2018-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.